Full spectrum flow cytometry-powered comprehensive analysis of PBMC as biomarkers for immunotherapy in NSCLC with EGFR-TKI resistance

被引：0
|
作者：
Juan Zhou
Xiangling Chu
Jing Zhao
Mengqing Xie
Jing Wu
Xin Yu
Yujia Fang
Yazhou Li
Xiyan Li
Chunxia Su
机构：
[1] Shanghai Pulmonary Hospital &,Department of Oncology, Department of Clinical Research Center
[2] Thoracic Cancer Institute,undefined
[3] Tongji University School of Medicine,undefined
[4] Righton Biotechnology Co.,undefined
[5] Ltd,undefined
来源：
Biological Procedures Online | / 25卷
关键词：
Non-small cell lung cancer (NSCLC); Epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) resistance; Immune checkpoint inhibitor (ICI) plus chemotherapy; Peripheral blood mononuclear cell (PBMC);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 10 条
  • [1] Full spectrum flow cytometry-powered comprehensive analysis of PBMC as biomarkers for immunotherapy in NSCLC with EGFR-TKI resistance
    Zhou, Juan
    Chu, Xiangling
    Zhao, Jing
    Xie, Mengqing
    Wu, Jing
    Yu, Xin
    Fang, Yujia
    Li, Yazhou
    Li, Xiyan
    Su, Chunxia
    BIOLOGICAL PROCEDURES ONLINE, 2023, 25 (01)
  • [2] Full Spectrum Flow Cytometry-powered Analysis of PBMC as Biomarkers for Immunotherapy in NSCLC with EGFR-TKI Resistance
    Zhou, J.
    Su, C.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S312 - S313
  • [3] Identification of biomarkers, pathways, and therapeutic targets for EGFR-TKI resistance in NSCLC
    Zhu, Leilei
    Gao, Shanshan
    Zhao, Xianya
    Wang, Ying
    LIFE SCIENCE ALLIANCE, 2023, 6 (12)
  • [4] Quantitative Analysis of ctDNA Differentiates Necessity for Repeat Biopsy in NSCLC Patients Developed EGFR-TKI Resistance
    Wang, Y.
    Wang, W.
    Tian, P.
    Li, W.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2368 - S2368
  • [5] Analysis of the lncRNA-miRNA-mRNA Network Reveals a Potential Regulatory Mechanism of EGFR-TKI Resistance in NSCLC
    Ding, Dandan
    Zhang, Jufeng
    Luo, Zhiming
    Wu, Huazhen
    Lin, Zexiao
    Liang, Weicheng
    Xue, Xingyang
    FRONTIERS IN GENETICS, 2022, 13
  • [6] Efficacy of immune checkpoint inhibitors in EGFR-Mutant NSCLC patients with EGFR-TKI resistance: A systematic review and meta-analysis
    Qian, Xiaoyu
    Guo, Xiaodan
    Li, Ting
    Hu, Wei
    Zhang, Lin
    Wu, Caisheng
    Ye, Feng
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [7] The Multi-Omics Analysis of Key Genes Regulating EGFR-TKI Resistance, Immune Infiltration, SCLC Transformation in EGFR-Mutant NSCLC
    Wang, Zhi
    Zhang, Lingling
    Xu, Wenwen
    Li, Jie
    Liu, Yi
    Zeng, Xiaozhu
    Zhong, Maoxi
    Zhu, Yuxi
    JOURNAL OF INFLAMMATION RESEARCH, 2022, 15 : 649 - 667
  • [8] COMPREHENSIVE ANALYSIS OF MECHANISMS ON ACQUIRED RESISTANCE OF LUNG CANCER AGAINST EGFR-TKI WITH SPECIAL REFERENCE TO ROLE OF PTEN EXPRESSION LOSS
    Yasumoto, Kosei
    Uramoto, Hidetaka
    Yoshimatsu, Takashi
    So, Tetsuya
    Nose, Naohiro
    Onitsuka, Takamitsu
    Tanaka, Fumihiro
    Ono, Mayumi
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S509 - S510
  • [9] Comprehensive analysis of human monocyte subsets using full-spectrum flow cytometry and hierarchical marker clustering
    Li, Chao
    Xiao, Maozhi
    Geng, Suxia
    Wang, Yulian
    Zeng, Lingji
    Lai, Peilong
    Gong, Ying
    Chen, Xiaomei
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [10] OMIP-084: 28-color full spectrum flow cytometry panel for the comprehensive analysis of human γδ T cells
    Barros-Martins, Joana
    Bruni, Elena
    Fichtner, Alina Suzann
    Cornberg, Markus
    Prinz, Immo
    CYTOMETRY PART A, 2022, 101 (10) : 856 - 861
1